StockCall Study on Humana, Unitedhealth, Aetna, and WellPoint

Wed Mar 27, 2013 8:00am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130327:nPn3278410


LONDON,  March 27, 2013  /PRNewswire/ --

The healthcare industry is undergoing a major transformation after the Supreme
Court last year upheld President Obama's Affordable Care Act (ACA). The ACA is
the biggest overhaul of the healthcare industry in decades. While critics of the
healthcare reform say that it will lead to rising costs for the healthcare
industry, supporters say that it will bring an increase in the number of insured
individuals, which will eventually benefit the industry. The reform will
definitely benefit providers of healthcare plans such as Humana Inc. (NYSE:
HUM), UnitedHealth Group Inc. (NYSE: UNH), Aetna Inc. (NYSE: AET), and WellPoint
Inc. (NYSE: WLP). Shares of all four companies edged higher in Tuesday's trading
session, tracking gains in the broad market, which rallied on the back of some
robust economic data. StockCall free coverage on HUM, UNH, AET, and WLP is
available upon registration at

http://www.stockcall.com/register

Shares of Humana Inc. edged higher on Tuesday; however, the gains were limited.
The stock closed 0.39% higher at  $66.70  on volume of 1.40 million. Humana's
shares, however, have fallen more than 2.40% in the last three sessions. For the
year so far, the stock has fallen more than 2.80%. The stock's MACD has recently
crossed below the signal line, which is a bearish signal. It is also trading
below its 50-day and 200-day moving averages, which further confirms the
downbeat trend. Humana's shares currently have support at  $66. Download the
free technical research on HUM by signing up at

http://www.StockCall.com/HUM032713.pdf

Shares of UnitedHealth Group Inc. rose sharply yesterday. The stock ended the
day 1.44% higher at  $55.65  on above average volume of 6.06 million. It touched
an intra-day high of  $55.78. UnitedHealth's shares are currently trading 7.30%
below their 52-week high of  $60.03. Year-to-date, the stock has gained 3%,
compared to a gain of over 9.60% for the S&P 500. However, the stock has been
gaining momentum since the start of this year. Its MACD has just crossed above
the zero-line and is also trading above the signal line, which is a bullish
signal. Register now and get access to the free analysis on UNH at

http://www.StockCall.com/UNH032713.pdf

Aetna Inc.'s shares also rose sharply on Tuesday, closing 1.10% higher at 
$50.60  on volume of 2.54 million. The stock touched an intra-day high of 
$51.15  earlier in the day. The company's. shares are currently trading close to
their 52-week high of  $51.73. The stock has outperformed the S&P 500 so far in
2013, gaining more than 9.70%. The Health Care Plans company's shares, however,
face stiff resistance at around  $51.50. The stock's MACD has also crossed below
the signal line, which is a bearish signal. Sign up and read the complimentary
report on AET at

http://www.StockCall.com/AET032713.pdf

Shares of WellPoint Inc. also gained more than 1% yesterday. The stock closed
1.01% higher at  $64.76  on volume of 1.21 million on Tuesday. WellPoint's
shares have seen a series of highs in the last three sessions, which is a
bullish signal. The stock is now trading close to  $65  resistance level.
WellPoint's shares are also trading above their 50-day and 200-day moving
averages, which is a bullish signal. The free report on WLP can be downloaded by
signing up now at

http://www.StockCall.com/WLP032713.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at

http://www.stockcall.com   

SOURCE  StockCall.com


Contact Person: William T. Knight, Email: info@stockcall.com, Contact Number:
+1(646)396-9857 (9:00 am EST - 01:30 pm EST)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.